Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06622486
Title First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Egle Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | ESP

Facility Status City State Zip Country Details
Centr Georges Francois Leclerc NOT_YET_RECRUITING Dijon France Details
Institut Regional Du Cancer De Montpellier RECRUITING Montpellier France Details
Institut Curie RECRUITING Paris France Details
Institut Gustave Roussy NOT_YET_RECRUITING Paris France Details
Hospital Universitari Vall D Hebron NOT_YET_RECRUITING Barcelona Spain Details
Hospital Universitario Fundacion Jimenez Diaz NOT_YET_RECRUITING Madrid Spain Details
Clinica Universidad De Navarra NOT_YET_RECRUITING Pamplona Spain Details
Hospital Clinico Universitario De Valencia RECRUITING Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field